Study | Reason for exclusion |
---|---|
Bird 1966 | It was unclear whether this trial was randomised and whether participants received either CBZ or PB as monotherapy. |
Castro‐Gago 1998 | The trial was not randomised, and the treatment choice was made based on types of seizures. |
Cereghino 1973 | This was a preliminary analysis of Cereghino 1974. |
Hansen 1980 | The trial was not randomised; participants were already on CBZ or PB monotherapy upon entry into the study. |
Kuzuya 1993 | The trial was not randomised; participants were already on CBZ or PB monotherapy upon entry into the study. |
Marjerrison 1968 | CBZ or PB therapy were added to current treatment. We could not make a comparison between CBZ monotherapy and PB monotherapy. |
Meador 1990 | We could not make a comparison between CBZ monotherapy and PB monotherapy. This was a cross‐over trial, but some participants were receiving treatment at the start of the first period, which had to be withdrawn slowly. |
Sabers 1995 | The trial was not fully randomised: "The treatment was chosen at random unless the individual diagnoses required a specific drug." |
Smith 1987 | This reported the same trial as Mattson 1985, and Mattson 1985 gave more relevant information. |
CBZ: carbamazepine PB: phenobarbitone